PMID- 25333643 OWN - NLM STAT- MEDLINE DCOM- 20150624 LR - 20220410 IS - 1791-2431 (Electronic) IS - 1021-335X (Linking) VI - 32 IP - 6 DP - 2014 Dec TI - Kruppel-like factor 8 involved in hypoxia promotes the invasion and metastasis of gastric cancer via epithelial to mesenchymal transition. PG - 2397-404 LID - 10.3892/or.2014.3495 [doi] AB - Previously, we reported that hypoxia was able to induce invasion and metastasis in gastric cancer and that hypoxia-inducible factor-1 (HIF-1) is a key factor involved in this tumor type. Kruppel-like factor 8 (KLF8) as a transcriptional repressor has been suggested as a promoter of tumor metastasis in breast cancer and an inducer of the epithelial‑mesenchymal transition (EMT). KLF8 is also highly expressed in gastric cancer tissues, contributing to poor prognosis. However, the association between KLF8 and HIF-1 in regulating the progression of human gastric cancer in hypoxia is unclear. In the present study, we found that KLF8 was overexpressed in gastric cancer metastatic tissues and cells. Additionally, KLF8 siRNA significantly inhibited SGC7901 cell invasion and migration compared with SGC7901, SGC7901/Scr-si cells. Hypoxia is thus able to induce KLF8 expression and EMT in SGC7901 cells. However, following the examination of changes in cell morphology and epithelial and mesenchymal markers, it was found that KLF8 siRNA and HIF-1 siRNA strongly reversed EMT in cells undergoing hypoxia. Furthermore, hypoxia-induced KLF8 overexpression was attenuated by HIF-1 siRNA. Experiments using luciferase promoter constructs resulted in a marked increase in the activity of cells exposed to hypoxia and decreased activity in cells co-transfected with HIF-1 siRNA. The chromatin immunoprecipitation assay revealed proximal HRE at -133 is the main HIF-1 binding site in the KLF8 promoter. In conclusion, the results demonstrated that KLF8 is actively enhanced by hypoxia and is a novel HIF-1 target. KLF8 is a novel EMT regulating transcription factor that involved in the progression of gastric cancer. The specific anti-EMT drugs in combination with anti-hypoxia are new promising cancer therapies. FAU - Liu, Na AU - Liu N AD - Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Wang, Yafang AU - Wang Y AD - Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Zhou, Yongan AU - Zhou Y AD - Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Pang, Hailin AU - Pang H AD - Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Zhou, Jing AU - Zhou J AD - Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Qian, Pei AU - Qian P AD - Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Liu, Lili AU - Liu L AD - Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China. FAU - Zhang, Helong AU - Zhang H AD - Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140918 PL - Greece TA - Oncol Rep JT - Oncology reports JID - 9422756 RN - 0 (HIF1A protein, human) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (KLF8 protein, human) RN - 0 (Kruppel-Like Transcription Factors) RN - 0 (Repressor Proteins) SB - IM MH - Adenocarcinoma/*metabolism/secondary MH - Animals MH - Binding Sites MH - Cell Hypoxia MH - *Epithelial-Mesenchymal Transition MH - Gene Expression MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Hypoxia-Inducible Factor 1, alpha Subunit/physiology MH - Kruppel-Like Transcription Factors MH - Mice, Nude MH - Neoplasm Invasiveness MH - Neoplasm Transplantation MH - Promoter Regions, Genetic MH - Repressor Proteins/*physiology MH - Stomach Neoplasms/*metabolism/pathology EDAT- 2014/10/22 06:00 MHDA- 2015/06/25 06:00 CRDT- 2014/10/22 06:00 PHST- 2014/04/14 00:00 [received] PHST- 2014/07/17 00:00 [accepted] PHST- 2014/10/22 06:00 [entrez] PHST- 2014/10/22 06:00 [pubmed] PHST- 2015/06/25 06:00 [medline] AID - 10.3892/or.2014.3495 [doi] PST - ppublish SO - Oncol Rep. 2014 Dec;32(6):2397-404. doi: 10.3892/or.2014.3495. Epub 2014 Sep 18.